|
Volumn 2, Issue 3, 2002, Pages 144-147
|
Pharmacogenomics and the challenge to privacy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
ARTICLE;
BONE MARROW SUPPRESSION;
CONTROLLED STUDY;
DNA FINGERPRINTING;
GENETIC ANALYSIS;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HUMAN;
INFORMED CONSENT;
LEUKEMIA;
MEDICAL ETHICS;
PHARMACOGENETICS;
PHARMACOGENOMICS;
PLEIOTROPY;
PRIORITY JOURNAL;
PROFESSIONAL SECRECY;
RISK BENEFIT ANALYSIS;
SEQUENCE DATABASE;
CONFIDENTIALITY;
DATABASES, FACTUAL;
DNA;
EMPLOYMENT;
HUMANS;
INFORMED CONSENT;
INSURANCE, HEALTH;
PHARMACOGENETICS;
|
EID: 0036366204
PISSN: 1470269X
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.tpj.6500110 Document Type: Article |
Times cited : (18)
|
References (29)
|